JP4677191B2 - 過敏性腸症候群処置剤 - Google Patents
過敏性腸症候群処置剤 Download PDFInfo
- Publication number
- JP4677191B2 JP4677191B2 JP2004039054A JP2004039054A JP4677191B2 JP 4677191 B2 JP4677191 B2 JP 4677191B2 JP 2004039054 A JP2004039054 A JP 2004039054A JP 2004039054 A JP2004039054 A JP 2004039054A JP 4677191 B2 JP4677191 B2 JP 4677191B2
- Authority
- JP
- Japan
- Prior art keywords
- ibs
- treatment
- present
- action
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ラットの拘束ストレスによる排便亢進の実験:
6令のSD系雄性ラットを各群6〜8匹に分け、実験前日より5連ケージにて個別飼育し、環境に馴化させた。また、餌および飲料水は実験当日の朝まで自由に摂取させた。
mg/錠
タンドスピロン 3.0
アロセトロン 1.0
でん粉 10.0
乳糖 74.0
カルボキシメチルセルロースカルシウム 10.0
タルク 1.0
ステアリン酸マグネシウム 1.0
100.0
タンドスピロン及びアロセトロンの混合物を70μm以下の粒度に粉砕し、それにでん粉、乳糖及びカルボキシメチルセルロースカルシウムを加えてよく混合する。10%のでん粉のりを上記混合粉体に加えて攪拌混合し、顆粒を製造する。乾燥後粒径を1000μm前後に整粒し、これにタルク及びステアリン酸マグネシウムを混合し、打錠する。
製剤例2
製剤例1と同様にして、錠剤を製造する。
タンドスピロン 5.0
でん粉 10.0
乳糖 73.0
カルボキシメチルセルロースカルシウム 10.0
タルク 1.0
ステアリン酸マグネシウム 1.0
100.0
製剤例3
製剤例1と同様にして、錠剤を製造する。
アロセトロン 2.0
でん粉 10.0
乳糖 76.0
カルボキシメチルセルロースカルシウム 10.0
タルク 1.0
ステアリン酸マグネシウム 1.0
100.0
Claims (1)
- アロセトロン(alosetron)、グラニセトロン(granisetron)、アザセトロン(azasetron)、トロピセトロン(tropisetron)、ラモセトロン(ramosetron)、オンダンセトロン(ondansetron)、レリセトロン(lerisetron)、シランセトロン(cilansetron)、イタセトロン(itasetron)、インディセトロン(indisetron)、ドラセトロン(dolasetron)及び(R)−ザコプリド((R)−zacopride)から選ばれるセロトニン受容体サブタイプ3(5−HT 3 )拮抗剤と、タンドスピロン(tandospirone)であるセロトニン受容体サブタイプ1A(5−HT 1A )作動剤の組み合わせからなり、それらを同時に、順次に又は間隔をおいて投与するための過敏性腸症候群(IBS:Irritable Bowel Syndrome)処置剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004039054A JP4677191B2 (ja) | 2004-02-16 | 2004-02-16 | 過敏性腸症候群処置剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004039054A JP4677191B2 (ja) | 2004-02-16 | 2004-02-16 | 過敏性腸症候群処置剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005225844A JP2005225844A (ja) | 2005-08-25 |
JP4677191B2 true JP4677191B2 (ja) | 2011-04-27 |
Family
ID=35000838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004039054A Expired - Fee Related JP4677191B2 (ja) | 2004-02-16 | 2004-02-16 | 過敏性腸症候群処置剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4677191B2 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1724267B1 (en) * | 2004-02-26 | 2013-11-06 | ASKA Pharmaceutical Co., Ltd. | Pyrimidine derivative |
KR101555882B1 (ko) | 2009-02-04 | 2015-09-30 | 에스케이케미칼주식회사 | 과민성 장 증후군의 예방 및 치료용 조성물 |
MX2013001234A (es) | 2010-08-05 | 2013-04-24 | Conrig Pharma Aps | Derivados deuterados de tandospirona como agonistas del receptor 5-hidroxitriptamina 1a. |
-
2004
- 2004-02-16 JP JP2004039054A patent/JP4677191B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2005225844A (ja) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2324484C2 (ru) | Антагонисты метаботропного глутаматного рецептора 5 (mglur5) и способ для профилактики и лечения гастроэзофагеальной рефлюксной болезни (варианты) | |
AU2008268463A2 (en) | Methods and compositions for treating disorders | |
CN105636438A (zh) | 一种包含ampk激活剂及血清素活性制剂之医药组合物及其用途 | |
UA119537C2 (uk) | ЗАСТОСУВАННЯ ЗАМІЩЕНИХ 2,3-ДИГІДРОІМІДАЗО[1,2-c]ХІНАЗОЛІНІВ ДЛЯ ЛІКУВАННЯ ЛІМФОМ | |
JP2011157372A (ja) | 機能性腸障害を処置する方法 | |
RU2672248C1 (ru) | Применение производного бензимидазола для лечения ночного кислотного прорыва | |
TW200427450A (en) | Pharmaceutical composition comprising histamine H3 receptor antagonist providing nasal decongestant effect | |
US20190192525A1 (en) | Apilimod compositions and methods for using same | |
WO2015127556A1 (en) | Methods and uses for inducing or facilitating defecation in a patient in need thereof | |
CN102711757A (zh) | 用于治疗肠易激综合征的方法和分析法 | |
JP2008156297A (ja) | セロトニン2bおよび/または2c受容体拮抗剤 | |
JP2017119702A (ja) | ギラン・バレー症候群に伴う神経因性疼痛の予防又は治療剤 | |
JP2017014224A (ja) | 帯状疱疹関連痛の急性期疼痛の予防又は治療剤 | |
WO2006118212A1 (ja) | 膵炎の予防および治療剤 | |
JPH11501051A (ja) | 強迫性障害、睡眠時無呼吸、性的機能障害、嘔吐および乗物酔いの処置を意図する医薬 | |
JP4677191B2 (ja) | 過敏性腸症候群処置剤 | |
Tonini et al. | 5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract | |
JP2024508514A (ja) | 選択的cb2受容体アゴニストによる処置の方法 | |
JPWO2004026296A1 (ja) | 抗ストレス性疾患組成物 | |
US20200368223A1 (en) | Methods for inhibiting phosphate transport | |
JP2011246478A (ja) | テルカゲパントカリウムの固形投与製剤 | |
Blandizzi et al. | Gastrointestinal drugs | |
US7842702B2 (en) | Treatment for irritable bowel syndrome | |
REID | New therapeutic agents for hypertension | |
JP2010528049A (ja) | 疼痛の治療のための医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070124 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070125 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080126 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100309 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100507 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100601 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100901 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20101006 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101116 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110105 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110125 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110131 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140204 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4677191 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |